CRISPR THERAPEUTICS AG

Ticker: CRSP CUSIP: H17182108 Class: NAMEN AKT

Yarbrough Capital, LLC's Holding History (CIK: 0001767686)

Note: Option positions (PUT/CALL) are excluded.

Q4 2024
Shares 8,399 Value ($000) $331 Avg Close $47.22 Range $38.20 - $59.07
Q3 2024
Shares 8,399 Value ($000) $395 Avg Close $50.74 Range $43.42 - $63.68
Q2 2024
Shares 8,399 Value ($000) $454 Avg Close $57.84 Range $51.02 - $68.39
Q1 2024
Shares 8,499 Value ($000) $579 Avg Close $71.59 Range $58.29 - $91.10
Q4 2023
Shares 8,499 Value ($000) $532 Avg Close $55.02 Range $37.55 - $76.97
Q3 2023
Shares 8,499 Value ($000) $386 Avg Close $51.65 Range $44.53 - $59.67
Q2 2023
Shares 8,499 Value ($000) $477 Avg Close $56.74 Range $43.10 - $72.00
Q1 2023
Shares 8,499 Value ($000) $384 Avg Close $48.57 Range $39.88 - $58.50
Q4 2022
Shares 100 Value ($000) $4 Avg Close $53.05 Range $38.94 - $66.31
Q4 2021
Shares 24,100 Value ($000) $1,826 Avg Close $87.36 Range $67.15 - $112.39